Abclon Inc.
AbClon Inc. is a South Korean biopharma innovator developing antibody therapeutics via its NEST, AffiMab, and CAR‑T platforms targeting solid tumors, hematologic cancers, and autoimmune diseases, positioning it for rapid market expansion.
Headquarters: South Korea (KOR)
- Website: Visit Site 🔗
- Type: Corporation
Company Profile
- Sector: Manufacturing
- Industry: Pharmaceutical Manufacturing
- HQ: Seoul
Unlock the full potential.
Upgrade
Get access to Relative P/E Ratio Valuation Histogram.